|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 148.87 USD | -1.29% |
|
+4.27% | +404.82% |
| 03/09 | Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line Rating | MT |
| 03/09 | Wall Street's Triple Squeeze |  |
| Market Cap | 5.94TCr 5.11TCr 4.8TCr 4.39TCr 8.19TCr 5,61800Cr 8.26TCr 57TCr 22TCr 2,87100Cr 22TCr 22TCr 9,24700Cr | P/E 2026 * |
-17.7x | P/E 2027 * | -30.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5.58TCr 4.8TCr 4.5TCr 4.12TCr 7.69TCr 5,27300Cr 7.75TCr 53TCr 21TCr 2,69500Cr 21TCr 20TCr 8,67900Cr | EV / Sales 2026 * |
26.6x | EV / Sales 2027 * | 23.5x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
|
Borsa Italiana
| 1MRNA | End-of-day quote | |
|
Boerse Muenchen
| 0QF | Real-time | |
|
Tradegate
| 0QF | Real-time | |
|
Xetra
| 0QF | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 0QF | Delayed | |
|
Wiener Boerse
| MRNA | End-of-day quote | |
|
Börse Stuttgart
| 0QF | Delayed | |
|
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
|
London S.E.
| 0A45 | Delayed | |
|
Mexican S.E.
| MRNA * | End-of-day quote | |
|
CBOE
| 0A45 | Real-time | |
|
Swiss Exchange
| MRNA | Delayed | |
|
Lima
| MRNAUS | End-of-day quote | |
|
Swiss Exchange
| MRNA | Delayed |
Last Transcript : Moderna, Inc.
| 1 day | -1.29% | ||
| 1 week | +4.27% | ||
| Current month | +6.08% | ||
| 1 month | +169.99% | ||
| 3 months | +203.44% | ||
| 6 months | +198.76% | ||
| Current year | +404.82% |
| 1 week | 133.86 |  | 156.42 |
| 1 month | 53.71 | | 176.66 |
| Current year | 29.81 | | 176.66 |
| 1 year | 22.28 | | 176.66 |
| 3 years | 22.28 | | 176.66 |
| 5 years | 22.28 | | 464.85 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Exercice | Chief Financial Officer | 818 | 0.0002% | ||
| 28/08/26 | Exercice | Chairperson | 1,518 | 0.0004% | ||
| 28/08/26 | Exercice | General Counsel | 818 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | +4.27% | +519.00% | +32.26% | 6.02TCr | |
| -1.00% | +4.43% | +49.60% | +1.42% | 8.51TCr | |
| -0.44% | +1.40% | -17.13% | -34.90% | 5.97TCr | |
| -1.60% | -7.34% | -5.08% | +31.05% | 5.11TCr | |
| +0.09% | -0.54% | +9.26% | +165.71% | 4.87TCr | |
| +0.83% | +1.36% | +58.53% | -15.97% | 3.29TCr | |
| -0.64% | +0.20% | +47.19% | +97.87% | 2.61TCr | |
| -0.10% | -4.65% | +2.40% | +197.10% | 2.26TCr | |
| +1.10% | -1.67% | +64.17% | +118.01% | 1.64TCr | |
| -5.19% | -9.15% | -20.63% | +740.91% | 1.53TCr | |
| Average | -0.82% | -1.39% | +70.73% | +133.35% | 4.18TCr | |
| Weighted average by Cap. | -0.76% | +0.27% | +92.28% | +70.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 210.1Cr 180.77Cr 169.63Cr 155.2Cr 289.68Cr 20TCr 291.97Cr 2.01TCr 781.49Cr 10TCr 788.95Cr 771.74Cr 33TCr | 243.77Cr 209.74Cr 196.83Cr 180.08Cr 336.11Cr 23TCr 338.77Cr 2.33TCr 906.76Cr 12TCr 915.41Cr 895.45Cr 38TCr |
| Net income | -331.26Cr -285.02Cr -267.46Cr -244.71Cr -456.74Cr -31TCr -460.35Cr -3.16TCr -1.23TCr -16TCr -1.24TCr -1.22TCr -52TCr | -194.48Cr -167.33Cr -157.03Cr -143.67Cr -268.15Cr -18TCr -270.27Cr -1.86TCr -723.42Cr -9.4TCr -730.33Cr -714.4Cr -30TCr |
| Net Debt | -365.29Cr -314.29Cr -294.94Cr -269.85Cr -503.65Cr -35TCr -507.64Cr -3.49TCr -1.36TCr -18TCr -1.37TCr -1.34TCr -57TCr | -216.92Cr -186.64Cr -175.14Cr -160.24Cr -299.08Cr -21TCr -301.45Cr -2.07TCr -806.87Cr -10TCr -814.57Cr -796.81Cr -34TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $148.87 | -1.29% | 1,32,90,379 |
| 02/26/02 | $150.81 | -2.24% | 1,65,63,188 |
| 01/26/01 | $154.27 | +9.93% | 2,58,31,743 |
| 31/26/31 | $140.34 | +1.70% | 1,85,70,704 |
| 28/26/28 | $137.99 | -3.35% | 2,58,20,563 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
